There are 3 papers on LYAR in aging research: 1 observational study in people, 1 in cells.
At a glance
The findings reach cells, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Humans1
- Cells1
- In silico1
Effects
1Adipogenesis
downin cells1
1 study
Adipogenesis
downin cells1
LYAR decreases adipogenesis in aged bone marrow.
“Decreased expression of Ly-1 antibody reactive clone (Lyar) triggers enhanced adipogenesis of bone marrow mesenchymal stromal cells in aged bone marrow”
Cellsin aged bone marrowbone marrow
PloS one
Associations
3BMMSC proliferation
upin cells1
1 study
BMMSC proliferation
upin cells1
LYAR is associated with BMMSC proliferation in cells.
“Lyar was not only implicated in the regulation of BMMSC proliferation”
Cellsbone marrow
PloS one
PI3K–AKT signaling
downin cells1
1 study
PI3K–AKT signaling
downin cells1
LYAR is associated with PI3K–AKT signaling in cells (aged bone marrow).
“An age-associated decline in Lyar expression was associated with a reduction in FGF2-PI3K-Akt1 signaling activity in aged bone marrow.”
Cellsaged bone marrowbone marrow
PloS one
Chronic periodontitis
upin silico1
1 study
Chronic periodontitis
upin silico1
LYAR is associated with chronic periodontitis in silico (Mendelian randomization analysis).
“MR indicated that GZMK, KLRG1, and LYAR had causal relationships”
In silicoMendelian randomization analysis
BioMed research international